Glythera, a biotech spin-out from the University of Bath, has raised £700k ($1m) from commercialisation company the IP Group. The funding is the result of the UK-based firm hitting commercial milestones following a £600k investment from the IP Group last year, which was used to entice Glythera to relocate in the north east of England.…
Glythera pockets $1m
Jul 15, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024